PRISM MediaWire

PRISM MarketView Launches Emerging AdTech and Media Index

Leading global companies work to strike balance between digital and traditional advertising

12 December 2023

MyMD Tackles Rheumatoid Arthritis with Launch of Phase 2 Trial in Early 2024

NEW YORK, NY, December 11, 2023 - The FDA has cleared an Investigational New Drug Application (IND) for MyMD Pharmaceuticals (Nasdaq: MYMD) to initiate a Phase 2 clinical trial of oral MYMD-1® as a treatment for rheumatoid arthritis (RA). The company plans to launch the...

11 December 2023

SKYX and GE Sign a Five-Year Renewal of a Global Licensing Master Service Agreement as SKYX Continues to Enhance its Market Penetration and Collaborations with U.S. and World Leading Strategic Companies

MIAMI, FL, December 11, 2023 - SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a SKYX Technologies) (the "Company" or "SKYX"), a highly disruptive platform technology company with 77 pending and issued patents globally and over 60 lighting and home décor websites, with a missio...

11 December 2023

PRISM MediaWire - Weekly Press Resume - Dec. 04 to Dec. 08, 2023

New York, December 8, 2023

8 December 2023

PRISM Analysis: Stocks Making the Biggest Moves in Thursday Trading

NEW YORK, NY, December 07, 2023 - PRISM MediaWire - US equities are settling mostly higher in Thursday midday trading, with big tech broadly higher as Google ($GOOG) rallies after the company’s launch of Project Gemini, an AI model trained to behave in human-like ways. A...

7 December 2023

PRISM Next Gen Tech Company Spotlight: The Glimpse Group’s Journey into the Future

NEW YORK, NY, December 07, 2023 - PRISM MediaWire - In the ever-evolving landscape of technological innovation, the Glimpse Group, Inc. (VRAR) emerges as a beacon of creativity and ingenuity, weaving a future where virtual and augmented realities seamlessly blend with ou...

7 December 2023

PRISM MarketView Biotech Index Top Mover Spotlight: Kamada (KMDA)

NEW YORK, NY, December 07, 2023 - PRISM MediaWire -PRISM MarketView, a leading provider of unbiased market insight and company news, highlights Kamada Ltd. (Nasdaq: KMDA), a commercial-stage global biopharmaceutical company with a portfolio of products for rare and serio...

7 December 2023

Oncocyte Begins FDA Submissions Process for VitaGraft Transplant Assays

-Significant unmet need for regulated product in $2B US testing market--Opportunity for expedited pathway for kitted product in development-

6 December 2023

PRISM MARKETVIEW HIGHLIGHTS ALTIMMUNE’S POSITIVE TOPLINE RESULTS IN OBESITY DRUG TRIAL

NEW YORK, NY, December 05, 2023 - PRISM MediaWire -PRISM MarketView, a leading provider of unbiased market insight and company news, highlights Altimmune, Inc. (Nasdaq: ALT) which has reported positive topline results from its 48-week MOMENTUM Phase 2 obesity trial of pe...

5 December 2023

PRISM MediaWire - Weekly Press Resume - Nov. 27 to Dec. 1, 2023

New York, December 1, 2023

1 December 2023